Media OutReach
Oriental Remedies Clinic Opens Fifth TCM Clinic in Punggol Coast Mall
New Clinic Opening for Families in Punggol Coast Mall
The new TCM clinic is designed as a welcoming space where families can experience the TCM principle of Yang Sheng, the art of life cultivation. More than just a treatment centre, it encourages individuals and children to build lifelong habits that promote balance, vitality, and preventive care.
Developed in collaboration with House on the Hill, a renowned Montessori preschool in Singapore, the clinic features a sensory-focused waiting area thoughtfully designed to engage children through their five senses, transforming passive waiting into active discovery. Children are invited to explore traditional Chinese herbs, textures, scents, and natural materials in a calm, tactile environment. This immersive setup encourages curiosity, independent participation, and self-directed play, reflecting our core belief in nurturing lifelong wellness from an early age.
Every aspect of the clinic promotes emotional comfort and a restorative atmosphere. A natural colour palette of muted greys and warm earth tones, complemented by carefully curated toys suited to different developmental stages, helps children feel grounded and focused. This intentional design supports emotional regulation and encourages internal awareness, an essential foundation for the mind-body connection central to TCM healing practices.
Enhancing Comfort with Child-Friendly Design
The clinic features an open-concept layout, where the paediatric pods for consultations and treatments are designed as a natural extension of the children’s play area, offering a seamless transition from exploration to treatment. This thoughtful continuity reduces anxiety by preserving a sense of familiarity and playfulness, helping consultations feel more conversational and less clinical.
These pods are intentionally designed to encourage gentle interaction, open communication and engagement, helping children stay emotionally regulated and present. This approach keeps children engaged and interested in their bodies and feelings, fostering a sense of ownership in their wellness journey.
The open-concept design facilitates parental supervision, allowing the clinic to foster guided independence in children. Through this approach, the clinic helps empower children to understand and make choices that support their well-being. This transparency is key to the collaborative, family-centred approach at Oriental Remedies Clinic.
Expanding Core Services to Support Paediatric Care
In addition to Oriental Remedies Clinic’s comprehensive suite of treatments, including acupuncture, herbal medication, paediatric tuina, and tech-enhanced therapies such as Electro-Lymphatic Therapy (ELT), the new branch will introduce more child-focused therapies, such as paediatric moxibustion, herbal vaporiser therapy, and Cell Pro Therapy for children. These specialised additions reflect the clinic’s dedication to delivering tailored, gentle, and effective care while actively encouraging children’s participation in their health education from an early age.
The Punggol outlet will also serve as an educational platform through intimate community workshops. Covering practical topics such as “Understanding Big Emotions through TCM,” “Supporting Your Child’s Immune System Naturally,” and “Healthy Foods for Your Body Constitution,” these workshops aim to reinforce the critical link between emotional resilience, physical health, and lifelong wellness.
Integrating Tradition with Technology in Punggol’s Digital District
Located at Punggol Coast Mall within the Punggol Digital District (PDD), the clinic’s opening aligns with Singapore’s push for innovation in healthcare. Oriental Remedies Clinic is actively exploring ways TCM can evolve through advancements in artificial intelligence, data analytics, and smart diagnostics.
Current initiatives include research into AI-assisted tongue and pulse diagnosis, and personalised treatment plans informed by data analytics. These advanced technologies aim to enhance the precision of care without compromising the personalised, hands-on essence of traditional TCM practice.
In the long term, the clinic hopes to collaborate with research institutions and tech firms within PDD to further integrate cutting-edge innovations into TCM. This forward-looking approach supports Oriental Remedies Clinic’s vision of becoming a modern, future-ready wellness provider—empowering practitioners with technology to deliver more precise, effective, and accessible care.
Supporting Healthier SG Through Early Education
The expansion into Punggol reflects Oriental Remedies Clinic’s dedication to Singapore’s Healthier SG initiative, which prioritises preventive care. Understanding that establishing strong health foundations begins in childhood, the new clinic aims to help introduce TCM principles and healthy lifestyle practices in an engaging manner.
By creating child-friendly spaces that foster curiosity and proactive exploration of natural remedies, the clinic chain helps children and families build strong foundations for lifelong health. This approach cultivates balanced living from an early age, ultimately reducing the incidence of chronic illnesses later in life.
Through empowering children to embrace healthy habits from a young age, the chain looks to actively contribute to a more resilient and healthier Singapore.
Serving the Punggol Community Through Holistic Care
According to Beatrice Liu, CEO and co-founder of Oriental Remedies Clinic, the decision to open a new branch in Punggol was driven by the area’s growing population and its high concentration of young families.“Punggol represents a vibrant, forward-looking community, and we see an immense opportunity to partner with these families on their wellness journeys,” says Ms. Liu.“Our focus on life cultivation means we are not just addressing immediate health concerns, but guiding individuals and families holistically through every stage of life, with care that evolves alongside them.”
The new clinic at Punggol Coast Mall is now open. First-time patients can enjoy a special launch offer for a limited time. For more information or to register, please use our form here.
Hashtag: #OrientalRemedies
https://www.orientalremediesgroup.com/
https://sg.linkedin.com/company/orientalremediesclinic
https://www.facebook.com/Orientalremediesgroup/
https://www.instagram.com/orientalremediesclinic
The issuer is solely responsible for the content of this announcement.
About Oriental Remedies Clinic
Oriental Remedies Clinic is a leading healthcare provider in Singapore that combines Traditional Chinese Medicine (TCM) with modern technology. The clinic has expanded from a single-physician practice to a team of bilingual practitioners, many of whom are trained in both Biomedical Science and TCM, combining scientific knowledge with the wisdom of traditional medicine.
Media OutReach
Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in three additional markets in Asia
Following the acquisition, Zuellig Pharma will now own the trademarks, marketing authorizations and license manufacturing know-how for Cialis®, a treatment for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), in 11 markets in Asia, with the expansion of its ownership into three additional markets beyond the original eight. Zuellig Pharma will also continue to promote and distribute the brand in these markets.
The expanded ownership of Cialis® will widen accessibility of the drug to a significant population of men in Asia who are affected by ED and BPH. The acquisition also aligns with Zuellig Pharma’s strategic priority of building a strong portfolio of owned prescription healthcare products as an integrated healthcare solutions company.
“Our acquisition of Cialis® in three additional markets builds on the strong foundation we established two years ago and highlights our proven success in scaling trusted brands effectively through our commercial capabilities and deep expertise. As we broaden our footprint, we remain focused on delivering sustainable growth and advancing our purpose of making in-demand healthcare solutions more accessible to communities in Asia,” said John Graham, CEO of Zuellig Pharma.
Hashtag: #ZuelligPharma #EliLillyandCompany #Cialis #MensHealth #Healthcare #Pharmaceuticals
https://www.zuelligpharma.com/
https://www.linkedin.com/company/zuellig-pharma
The issuer is solely responsible for the content of this announcement.
About Zuellig Pharma
Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to the communities we serve. We provide world-class distribution, commercialization, and clinical trial support services, underpinned by a strong culture of innovation to support the growing healthcare needs in this region. The company was founded a hundred years ago and has grown to become a multibillion-dollar business covering 18 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.
Media OutReach
Ingdan Powers Embodied AI with Humanoid-Style Brain-Cerebellum Chipset to Boost Robotics Ecosystem
2026 is widely regarded as a milestone year for humanoid robotics, in which humanoid robots transition from laboratory prototypes and demonstration performances to large‑scale mass production. At CES in January, NVIDIA announced the commercial launch of its physical‑AI core platform Jetson Thor. Tesla is scheduled to officially release the mass‑production engineering version of its Optimus (V3) humanoid robot by the end of March, with plans to initiate million‑unit‑level production lines by the end of 2026—an inflection point widely regarded as the “Model 3 moment” of the humanoid robotics industry. At the same time, Chinese robotics companies such as AGIBOT, Unitree, and Fourier Intelligence have already deployed products at scale in warehousing and logistics scenarios.
Against this backdrop, the upstream hardware focus of the humanoid robotics industry is increasingly converging on “Brain-Cerebellum” collaboration and low‑latency, multi‑joint real‑time control, which are essential to achieving coordinated, smooth, and human‑like robotic motion. During the CMG Spring Festival Gala, robots from multiple companies demonstrated complex coordinated movements and dexterous hand operations, further highlighting the value of this technical direction.
D‑Robotics, originating from the AIoT and robotics division of Horizon Robotics, focuses on edge‑side embodied intelligence solutions characterized by high computing power, integrated computation and control, and low latency. Leveraging its parent company’s long‑term experience in intelligent driving, D‑Robotics has established a precise position in humanoid robot “Brain-Cerebellum” coordination and real‑time joint control.
In November 2025, D‑Robotics unveiled its flagship robotics computing platform S600, with an official release planned for the end of the first quarter of 2026. The S600 platform features a highly integrated humanoid‑style “Brain-Cerebellum” chipset architecture. Its “Brain” configuration combines an 18‑core A78AE CPU with a proprietary Nash‑architecture BPU, delivering 560 TOPS (INT8) edge computing power and supporting efficient deployment of VLA, VLM, LLM, and locomotion models. Its “Cerebellum” configuration integrates a 6‑core R52+ MCU, providing high‑reliability, real‑time motion control.
By integrating CPU, BPU, and real‑time MCU capabilities into a single SoC, S600 enables a closed‑loop architecture encompassing perception, decision‑making, and real‑time action control. This design addresses a key industry challenge in which many edge AI processors lack embedded real‑time MCUs and rely on external controllers, resulting in excessive latency. The integrated MCU supports high‑frequency, high‑precision PWM signal generation based on FOC algorithms, enabling precise motor control and contributing to stable rhythm and natural gait.
The S600 platform has been adopted by multiple robotics companies such as Fourier Intelligence, Booster Robotics, X Square Robot, and ROBOTERA, supporting applications that require stable multi‑joint coordination and smooth motion performance.
Ingdan, Inc. (00400.HK) is a core supplier in the AI computing power supply chain and an application technology solutions provider covering both AI infrastructure and AI intelligent terminals. The Company represents a broad portfolio of international semiconductor manufacturers, including NVIDIA, Xilinx, Intel, AMD, and SanDisk, as well as numerous domestic chip vendors. It serves hundreds of robotics manufacturers and Tier‑1 customers and has formed a comprehensive embodied intelligence ecosystem.
D‑Robotics is a core product line Ingdan distributes . Building on D‑Robotics’ products and combined with its own technical services—such as multi‑sensor fusion development, real‑time closed‑loop tuning, Quantization‑Aware Training (QAT) support, simulation testing, and modular SOM customization—the Group has supported sophisticated customers including Galbot and ROBOTERA, continuously enriching the robotics industry ecosystem.
Looking ahead, Ingdan will continue to focus on the humanoid robotics sector. Leveraging an IC product matrix centered on NVIDIA Jetson and D‑Robotics platforms, the Company aims to further strengthen its AI intelligent terminal capabilities and continue supporting the iterative development of embodied intelligence products.
For investor and media enquiries
Please email to **@****an.com
Hashtag: #Ingdan #Chips #humanoid #D‑Robotics #NVIDIA #Tech
The issuer is solely responsible for the content of this announcement.
Ingdan, Inc.
Ingdan, Inc. (00400.HK) is a core supplier in the AI computing power supply chain and an application technology solutions provider covering both AI infrastructure and AI intelligent terminals. The Company represents a broad portfolio of international semiconductor manufacturers, including NVIDIA, Xilinx, Intel, AMD, and SanDisk, as well as numerous domestic chip vendors. It serves hundreds of robotics manufacturers and Tier‑1 customers and has formed a comprehensive embodied intelligence ecosystem.
Media OutReach
Snow, Ice, and Performance: 2026 Changan Global Testing Season Arrives in Europe with Back-to-Back Winter Events
- European dealers and journalists experienced the CHANGAN DEEPAL S05 AWD at 2026 Changan Global Testing Season this February.
- With intelligent AWD and advanced ADAS, the CHANGAN DEEPAL S05 AWD offered uncompromising safety and control on winter roads.
Saalfelden, Austria – Media OutReach Newswire – 12 March 2026 – Following extreme cold tests in Yakeshi, China, the 2026 Changan Global Testing Season made its European debut this February with the Changan Winter Experience in Courmayeur and the Winter Test Drives in Saalfelden. The all-electric CHANGAN DEEPAL S05 AWD was tested on snow and ice—familiar conditions for European drivers—offering dealers and journalists an immersive introduction to Changan’s electric mobility vision through dynamic drives.
Three-time Olympic gold medalist and Milano Cortina 2026 Ambassador Deborah Compagnoni joined the event in Courmayeur, testing the CHANGAN DEEPAL S05 AWD. Her career—defined by determination, control, and reliability—reflects Changan’s core values. “I felt that the principles of trajectory and speed in skiing apply to driving. With this model, you gain confidence on challenging terrain,” she said.
Snow-Validated Performance: The CHANGAN DEEPAL S05 AWD
Tested in Europe, the CHANGAN DEEPAL S05 AWD demonstrated controllable dynamics, reliable traction, and enhanced safety—highlighting its cutting-edge AWD and ADAS. The system adapts seamlessly: ECO/COMFORT modes prioritize RWD efficiency, while AWD will engage automatically when sensors detect slip, high torque demand, or extreme cold below -25°C. SPORT mode delivers permanent 50:50 torque for sharper response. SNOW mode maintains balanced torque with optimized slip control for confident driving on low-grip surfaces.
The intelligent AWD system delivers up to 320 kW power, 502 Nm torque, and 0–100 km/h acceleration in 5.5 seconds. It also improves hill climbing with a 40% gradient capability, ensures stability by actively balancing power to prevent skidding, and enables safer cornering at higher speeds through optimized grip and vehicle dynamics.
Changan Standard: Proven in the Alps, Bound for the World
Changan Standard is defined by a principle: forged in extremes, built for every day. From Yakeshi to the Alps, the test environments are selected to verify specific performance attributes—safety technologies, chassis response, all-wheel-drive calibration, and ADAS in low-grip scenarios. The objective of 2026 Global Testing Season is not to demonstrate extremes, but to confirm consistency: that the same level of safety, control, and stability demonstrated will be replicated in Mexico, Thailand, and Saudi Arabia.
Hashtag: #Changan
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn